Allogeneic stem cell transplantation with reduced-intensity, fludarabine-based conditioning in relapsed and refractory Hodgkin's disease: Low transplant-related mortality and impact of intensity of conditioning regimen on survival.

被引：0
作者：
Anderlini, P [1 ]
Saliba, R [1 ]
Donato, M [1 ]
Giralt, S [1 ]
Andersson, B [1 ]
Ueno, NT [1 ]
Khouri, IF [1 ]
de Lima, M [1 ]
Ippoliti, C [1 ]
Champlin, RE [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2135.2135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2135
引用
收藏
页码：587A / 587A
页数：1
相关论文
共 50 条
  • [31] The impact of donor lymphocyte infusions following reduced-intensity conditioning allogeneic stem cell transplantation for Hodgkin's disease
    Robinson, S. P.
    Canals, C.
    Taghipour, G.
    Martino, R.
    Michallet, M.
    Carella, A. M.
    Liakopoulou, E.
    Sureda, A.
    Schmitz, N.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S24 - S24
  • [32] Thiotepa and fludarabine as reduced-intensity conditioning regimen followed by allogeneic peripheral stem cell transplantation for hematologic malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Varettoni, M
    Rumi, E
    Baraté, C
    Ardizzone, F
    Lazzarino, M
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S155 - S155
  • [33] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    E P Alessandrino
    P Bernasconi
    A A Colombo
    D Caldera
    L Malcovati
    D Troletti
    L Vanelli
    M Varettoni
    F Montanari
    M Lazzarino
    [J]. Bone Marrow Transplantation, 2004, 34 : 1039 - 1045
  • [34] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Troletti, D
    Vanelli, L
    Varettoni, M
    Montanari, F
    Lazzarino, M
    [J]. BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1039 - 1045
  • [35] Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia
    Delioukina, Maria L.
    Palmer, Joycelynne M.
    Thomas, Sandra H.
    Krishnan, Amrita
    Stiller, Tracey
    Forman, Stephen J.
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (04) : 719 - 723
  • [36] Impact of Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation on Women's Fertility
    Assouline, Emmanuelle
    Crocchiolo, Roberto
    Prebet, Thomas
    Broussais, Florence
    Coso, Diane
    Gamerre, Marc
    Vey, Norbert
    Blaise, Didier
    Courbiere, Blandine
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06) : 704 - 710
  • [37] Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience
    Le Gouill, S.
    Kroeger, N.
    Dhedin, N.
    Nagler, A.
    Bouabdallah, K.
    Yakoub-Agha, I.
    Kanouni, T.
    Bulabois, C. E.
    Tournilhac, O.
    Buzyn, A.
    Rio, B.
    Moles, M. P.
    Shimoni, A.
    Bacher, U.
    Ocheni, S.
    Milpied, N.
    Harousseau, J. L.
    Moreau, P.
    Leux, C.
    Mohty, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (10) : 2695 - 2703
  • [38] Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    Christopoulos, P.
    Schmoor, C.
    Waterhouse, M.
    Marks, R.
    Waesch, R.
    Bertz, H.
    Finke, J.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (07) : 901 - 907
  • [39] Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
    Bertz, H
    Illerhaus, G
    Veelken, H
    Finke, J
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (01) : 135 - 139
  • [40] Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    P Christopoulos
    C Schmoor
    M Waterhouse
    R Marks
    R Wäsch
    H Bertz
    J Finke
    [J]. Bone Marrow Transplantation, 2013, 48 : 901 - 907
12345